A Study of LP-118 in Patients With Advanced Tumors
NCT05025358
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Lymphoma, Non-Hodgkin
Interventions
DRUG:
LP-118 tablet
Sponsor
Guangzhou Lupeng Pharmaceutical Company LTD.